Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

DURECT Corporation (DRRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5148-0.0377 (-6.82%)
At close: 04:00PM EDT
0.5102 -0.00 (-0.89%)
After hours: 04:04PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • l
    little
    “We continue to expect to enroll the last patient in the AHFIRM trial in mid-2023, which should enable top-line results to be reported in the second half of 2023.” That’s what DRRX said in the last Q report. Now they said “Enrollment expects to complete in Q2.” Seems to me they move earlier a little bit. No delay! That should be good in my view.
  • s
    sablegules
    What are the chances this thing passes phase 2b?
  • g
    guttums
    Yes it is a good news. They added 30 patients in 8weeks. Now, they also added more institutional sites with a total of 67 sites recruiting and going well. . The new sites are big teaching hospitals. They see the sickest ones. IMO, the study will be done by earlier than the first Q or earlier. . IMO the life saving drug will sell. Every GI guy in the large hospitals knows about this. A small sales team will do once approved. Let us hope the results will be spectacular..
  • j
    j37
    Will there be a press release about the 2M$ payment?
    Bullish
  • A
    Anonymous
    WOOHOO ..... let the games begin. Congrats to all longs (at last).
  • A
    Anonymous
    One of my holdings had to be red today.
  • l
    little
    Anonymous, do you have an interest here? Or just here to make fun of small people?
  • A
    Anonymous
    LOL!!! Get use to this because by the time earnings and vote on reverse split comes in early November there will be very little buying by anyone so low volume and no support. Price action will continue to fall. This may be in the .30’s if not .20’s by then.
  • R
    Rom
    They won't finish recruitment for the AHFIRM trial before Feb or March....then another 3 months for observing the last patient....then cleaning any data before they press the button on 'unblinding' results. Then analysis.

    We are talking Aug-Sept 23.

    Close shop for a year people on this one.
  • s
    sablegules
    Anyone buying here?
  • s
    sablegules
    Wow…what a give back from that 100% run…BUT let’s see where this commercialization tape bomb pushes it
  • A
    Anonymous
    One of my holdings had to be green this morning.
  • K
    Know One Knows
    Whats with this stock? Does it even know what green looks like? Nothing but red since I bought it!
  • j
    j37
    2$ in 2 weeks?
    Bullish
  • s
    sablegules
    Safe haven stock…lol!
  • j
    j37
    Well, we seem to be past the little noisy spot and back to slow, steady climb.

    When will there be Posimir news? How long does it take to launch something like Posimir?
    Bullish
  • f
    frank
    No Volume?
  • A
    Anonymous
    Hahahaha!!!!!
  • s
    sablegules
    What is the reason for this move?? Anyone?
  • s
    sablegules
    This would be called accumulation - before the next blast off.
Advertisement
Advertisement